Positive Test Results Reported for Teva-Sanofi Drug for Ulcerative Colitis, Crohn's

Key TakeawaysTeva Pharmaceuticals and Sanofi on Tuesday reported positive results in a Phase 2b trial of their drug for ulcerative colitis and Crohn's disease.The companies plan to provide further details about the research at a scientific forum in 2025.Teva and Sanofi said they would start a Phase 3 study of the treatment pending discussions with regulators.Both pharmaeuticals companies' U.S.-traded stocks gained after the news Tuesday, with Teva at its highest level in six years. U.S.-traded shares of Tev ...